AII Am Integrity posts 38 percent Q4 2025 EPS beat stock gains 112 percent as investors react positively to strong results Sangamo Therapeutics SGMO Stock Momentum Analysis Sangamo Therapeutics posts 797 downside EPS miss IVDA Iveda Solutions beats Q2 2024 EPS expectations by 412 percent but stock slips 067 percent in todays trading VBNK VersaBank posts 131 percent Q1 2026 EPS miss as net interest margin pressures crimp quarterly profitability PDSB PDS shares drop 11 percent despite Q4 2025 per share loss coming in narrower than analyst estimates FBIN Fortune posts 154 Q4 2025 EPS miss prompting a 258 drop in its share price during todays session